Clinical Trials in New York

Showing 981-1000 of 19,464 trials

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

NCT07486713

A open-label drug-drug interaction (DDI) study to evaluate the effects of olutasidenib on the pharmacokinetics (PK) of a CYP450 and OATP1B1 probe substrate cocktail in participants with IDH1 mutation-positive malignancies.

AML (Acute Myeloid Leukemia)GliomaCholangiocarcinoma+1 more

Rigel Pharmaceuticals16 participantsStarted Feb 2026

Orange, California, United States • New York, New York, United States

TERMINATEDPhase 4< 1 mile

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)

NCT05312970

The purpose of this study is to observe insights into the benefits of Varithena compared to Endothermal Ablation (ETA) in the treatment of the great saphenous vein.

Varicose Veins

Boston Scientific Corporation43 participantsStarted Feb 2023

Darien, Connecticut, United States • Washington D.C., District of Columbia, United States • Houma, Louisiana, United States +6 more locations

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)

Find Trials by Condition in New York

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Using MASL to Combat Oral Cancer

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

A Phase 2/3 Study in Adult and Adolescent Participants With SCD

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo